2025 Conference

2025 AHPBCC Annual Conference

Collaborating for Sustainable Progress in HPB Cancer Care, Education, and Research in Africa

August 12-16^th, 2025

Protea Wanderers Hotel and Conference Center, Johannesburg, South Africa

Conference Overview

The Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC) will hold its fourth annual scientific conference in Johannesburg, South Africa.

Building on the success of the previous conferences in Cairo (2022), Accra (2023), and Mombasa (2024)—which saw participation grow from 162 to 264 attendees across 23 to 29 countries—the 2025 event is expected to welcome over 300 participants from Africa and around the world. It will bring together a multidisciplinary audience, including specialists in medical and radiation oncology, gastroenterology, surgical oncology, pathology, radiology, and cancer biology, among other key fields.

HPB cancers in Africa present unique epidemiological challenges, with higher incidence rates, earlier onset, and significantly greater mortality than in other global regions. The 2025 conference will focus on understanding underlying risk factors, developing sustainable research strategies, and implementing practical interventions to reduce cancer burden and improve patient outcomes.

The conference will feature a robust scientific program, with highlights including:

Pre-conference workshops on grant writing, advanced endoscopy, surgical techniques, and patient advocacy.
Plenary sessions led by internationally renowned experts, including:
- Dr. Peggy Oti-Boateng – Biomedical science training
- Prof. Eduard Jonas – Addressing clinical management gaps
- Dr. Eileen O’Reilly – Advancements in precision therapies
Cutting-edge discussions on precision medicine, AI applications in oncology, innovative detection strategies, and clinical training models.
Opportunities for early-career investigators to gain advanced training, collaborate with global experts, and access research funding opportunities.

With sponsorship from organizations like Mayo Clinic Comprehensive Cancer Center and additional sponsorship opportunities available, the 2025 AHPBCC Conference will serve as a catalyst for research, clinical innovation, and policy advancement.

Mission

Our mission is to bring together leading experts and innovators in HepatoPancreatoBiliary (HPB) cancer research and care. We aim to foster collaborative efforts, promote cutting-edge research, and facilitate knowledge exchange to advance the diagnosis, treatment, and understanding of HPB cancers, with a special focus on integrating global and African perspectives.

Vision

Our vision is to establish a platform for groundbreaking progress in HPB cancer research and care. We strive to create an environment that nurtures international collaboration, driving significant advancements in patient care and outcomes, and setting new standards in the global fight against HPB cancers.

Testimonials

"The 2023 AHPBCC Conference in Accra was a milestone event in HPB cancer research. Collaborating with GASLIDD added immense value. It was inspiring to see such diverse expertise converging to tackle HPB cancers, offering fresh perspectives and innovative solutions."

"Attending the 2nd AHPBCC Annual Conference was an enlightening experience. The quality of research presentations and the depth of discussions on hepatobiliary and pancreatic cancers were exceptional. It's exciting to be part of a global effort that's making real progress in this field."

"As a patient advocate, the 2023 AHPBCC Conference was a profound journey. Hearing from leading experts and connecting with others from the patient community provided hope and reassurance that we are moving towards better care and understanding of HPB cancers."

"The interdisciplinary approach of the 2023 AHPBCC Conference, coupled with the involvement of GASLIDD, created a rich environment for learning and collaboration. It was an invaluable opportunity to discuss genetic research in HPB cancers with peers from different continents."